Brought to you by 
Abbott to pay $3.72bn for Piramal's branded generics business
27 May 2010
Executive Summary
In a transaction that will make it the leading pharma company in India with a 7% market share, Abbott Laboratories Inc. is acquiring Piramal Healthcare Ltd.'s healthcare solutions business for $2.12bn up front, plus $400mm annually for the next four years starting in 2011.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- OTC, Consumer
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Abbott to pay $3.72bn for Piramal's branded generics business
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice